Anticonvulsant drugs. I. Patho-physiological and pharmacological aspects.
D000085:Acetates / Q000627:therapeutic use; D000086:Acetazolamide / Q000494:pharmacology / Q000627:therapeutic use; D000927:Anticonvulsants; D002220:Carbamazepine / Q000494:pharmacology / Q000627:therapeutic use; D003975:Diazepam / Q000494:pharmacology; D003984:Dibenzazepines / Q000627:therapeutic use; D004569:Electroencephalography; D004828:Epilepsies, Partial / Q000188:drug therapy; D004827:Epilepsy / Q000188:drug therapy; D005013:Ethosuximide / Q000494:pharmacology; D006801:Humans; D010634:Phenobarbital / Q000494:pharmacology / Q000627:therapeutic use; D010672:Phenytoin / Q000494:pharmacology / Q000627:therapeutic use; D011324:Primidone / Q000494:pharmacology; D012640:Seizures / Q000145:classification / Q000188:drug therapy; D013388:Succinimides / Q000627:therapeutic use; D013843:Thiazines / Q000494:pharmacology / Q000627:therapeutic use; D014293:Trimethadione / Q000494:pharmacology / Q000627:therapeutic use
D000085:Acetates; D000927:Anticonvulsants; D003984:Dibenzazepines; D013388:Succinimides; D013843:Thiazines; D011324:Primidone; D002220:Carbamazepine; D005013:Ethosuximide; D010672:Phenytoin; D000086:Acetazolamide; D003975:Diazepam; D014293:Trimethadione; D010634:Phenobarbital